Xingfan Biotechnology Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
4
Xingfan Biotechnology General Information
Description
Provider of drug development services intended to create differentiated small-molecule drugs for oncology treatment. The company offers oncology drug development, small-molecule drug research, clinical trial translation services, pharmaceutical research collaboration, and project transaction services, enabling the pharmaceutical industry to address unmet medical needs through efficient research and clinical translation.
Contact Information
Corporate Office
- Unit O, 5th Floor
- Number 780 Cailun Road, China Pilot Free Trade Zone
- Shanghai, 201203
- China
Corporate Office
- Unit O, 5th Floor
- Number 780 Cailun Road, China Pilot Free Trade Zone
- Shanghai, 201203
- China
Xingfan Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 16-Apr-2026 | Completed | Generating Revenue |
Xingfan Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guxin Capital | Growth/Expansion | Minority | ||
| IDG Capital | Venture Capital | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority | ||
| Teng Yuan Capital | Venture Capital | Minority |
Xingfan Biotechnology FAQs
-
When was Xingfan Biotechnology founded?
Xingfan Biotechnology was founded in 2024.
-
Where is Xingfan Biotechnology headquartered?
Xingfan Biotechnology is headquartered in Shanghai, China.
-
What industry is Xingfan Biotechnology in?
Xingfan Biotechnology’s primary industry is Drug Discovery.
-
Is Xingfan Biotechnology a private or public company?
Xingfan Biotechnology is a Private company.
-
What is Xingfan Biotechnology’s current revenue?
The current revenue for Xingfan Biotechnology is .
-
Who are Xingfan Biotechnology’s investors?
Guxin Capital, IDG Capital, Suzhou Oriza Holdings Corporation, and Teng Yuan Capital have invested in Xingfan Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process